What they were paid
Orchestra BioMed Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $50,417 | $135,664 | $205,417 | $0 | $391,498 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Orchestra BioMed Holdings, Inc. DEF 14A filed April 29, 2026, accession 0001104659-26-051570, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Orchestra BioMed pays directors a $45,000 cash retainer and $125,000 in NSOs and RSUs.
Committees
FY2025 · as the proxy prints themAudit
The rest of the Orchestra BioMed board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Darren R. Sherman | Director | $0 |
| David P. Hochman | Chair of the Board | $0 |
| David Pacitti | Independent Director | $226,500 |
| Eric S. Fain, M.D | Lead Independent Director | $259,000 |
| Jason M. Aryeh | Independent Director | $226,500 |
| John Mack | Independent Director | $219,000 |
| Pamela Y. Connealy | Independent Director | $234,000 |
The full Orchestra BioMed compensation record
free company briefThis page is one director within Orchestra BioMed's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat